Total Payments
$7,856
2024 Payments
$984.14
Companies
44
Transactions
312
Medicare Patients
971
Medicare Billing
$128,199
Payment Breakdown by Category
Food & Beverage$7,747 (98.6%)
Education$108.97 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,747 | 309 | 98.6% |
| Education | $108.97 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $2,077 | 63 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,226 | 62 | $0 (2024) |
| Gilead Sciences, Inc. | $959.39 | 55 | $0 (2024) |
| Insmed, Inc. | $520.06 | 17 | $0 (2023) |
| Organogenesis Inc. | $515.98 | 16 | $0 (2024) |
| ABBVIE INC. | $467.66 | 6 | $0 (2023) |
| Smith+Nephew, Inc. | $426.11 | 19 | $0 (2024) |
| Melinta Therapeutics, LLC | $380.12 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $138.81 | 2 | $0 (2024) |
| Janssen Products, LP | $115.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $984.14 | 31 | Merck Sharp & Dohme LLC ($242.81) |
| 2023 | $1,214 | 42 | Merck Sharp & Dohme LLC ($297.75) |
| 2022 | $1,313 | 45 | ABBVIE INC. ($369.08) |
| 2021 | $1,156 | 42 | ViiV Healthcare Company ($573.94) |
| 2020 | $623.80 | 25 | Insmed, Inc. ($144.93) |
| 2019 | $1,171 | 66 | ViiV Healthcare Company ($333.80) |
| 2018 | $1,181 | 52 | ViiV Healthcare Company ($321.11) |
| 2017 | $213.46 | 9 | Smith & Nephew, Inc. ($121.88) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: ANTIBIOTICS | ||||||
| 11/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: ANTIBIOTIC | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/17/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Pharma Products | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/24/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), ZERBAXA, DIFICID | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/17/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ANTIBIOTIC | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.37 | General |
| 08/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/23/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $108.38 | General |
| 07/16/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: HIV | ||||||
| 05/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.62 | General |
| 05/21/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ANTIBIOTICS | ||||||
| 04/30/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Rezzayo | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ANTIBIOTICS | ||||||
| 04/23/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: HIV | ||||||
| 04/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ANTIBIOTIC | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/27/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Rezzayo | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: ANTIBIOTICS | ||||||
| 03/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/12/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 124 | 449 | $63,668 | $21,036 |
| 2022 | 6 | 117 | 312 | $47,553 | $17,994 |
| 2021 | 8 | 202 | 492 | $67,690 | $29,797 |
| 2020 | 10 | 528 | 1,189 | $145,990 | $59,371 |
Total Patients
971
Total Services
2,442
Medicare Billing
$128,199
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 26 | 182 | $27,300 | $7,740 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 65 | $13,266 | $5,107 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 72 | $9,934 | $3,537 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 40 | $5,519 | $2,358 | 42.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 27 | 90 | $7,650 | $2,295 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 96 | $19,593 | $8,828 | 45.1% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 19 | 86 | $12,900 | $3,785 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 31 | $4,343 | $1,621 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 30 | $4,139 | $1,455 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 11 | 35 | $2,975 | $898.16 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 16 | $2,235 | $874.30 | 39.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 18 | $1,369 | $532.56 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 150 | $27,054 | $14,423 | 53.3% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 22 | 93 | $12,330 | $4,170 | 33.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 40 | $4,924 | $2,245 | 45.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 23 | 38 | $5,205 | $2,072 | 39.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 35 | $4,037 | $1,803 | 44.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 59 | $5,761 | $1,723 | 29.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 20 | 54 | $4,165 | $1,487 | 35.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 12 | $2,295 | $940.80 | 41.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,920 | $933.46 | 48.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 128 | 372 | $44,640 | $11,287 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 99 | 183 | $24,705 | $10,274 | 41.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 76 | 87 | $17,345 | $9,208 | 53.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 93 | $11,160 | $7,242 | 64.9% |
About Dr. John Fried, MD
Dr. John Fried, MD is a Infectious Disease healthcare provider based in Overland Park, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689752909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Fried, MD has received a total of $7,856 in payments from pharmaceutical and medical device companies, with $984.14 received in 2024. These payments were reported across 312 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,747).
As a Medicare-enrolled provider, Fried has provided services to 971 Medicare beneficiaries, totaling 2,442 services with total Medicare billing of $128,199. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Overland Park, KS
- Active Since 11/02/2006
- Last Updated 01/20/2022
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689752909
Products in Payments
- DOVATO (Drug) $1,446
- PIFELTRO (Drug) $519.50
- Arikayce (Drug) $392.28
- DIFICID (Drug) $319.61
- Puraply (Medical Supply) $303.32
- Santyl (Drug) $264.93
- ZERBAXA (Drug) $200.60
- JULUCA (Drug) $191.01
- Kimyrsa (Drug) $165.95
- TRIUMEQ (Drug) $155.38
- TEFLARO (Drug) $149.00
- Vabomere (Drug) $147.97
- CABENUVA (Biological) $143.10
- AVYCAZ (Drug) $133.59
- Grafix PRIME (Biological) $122.09
- Descovy (Drug) $122.06
- APRETUDE (Biological) $119.68
- PREZCOBIX (Drug) $115.05
- Fetroja (Drug) $113.83
- Biktarvy (Drug) $113.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Overland Park
Dr. Apoorv Kalra, Md, MD
Infectious Disease — Payments: $3,396
Infectious Disease $3,396
Michael Driks, M.d, M.D
Infectious Disease — Payments: $2,163
Infectious Disease $2,163
Jared Frisby, Do, DO
Infectious Disease — Payments: $278.24
Infectious Disease $278.24
Himal Bajracharya, M.d, M.D
Infectious Disease — Payments: $11.95
Infectious Disease $11.95
Dr. William Downham, M.d, M.D
Infectious Disease
Infectious Disease
Glenn Hodges, Md, MD
Infectious Disease
Infectious Disease